Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration.

ADP-ribosylation factor 4 (ARF4) is a member of the Ras superfamily of small guanine nucleotide-binding proteins. ARF4 is known to interact with the epidermal growth factor receptor (EGFR) and mediates the EGF-dependent signal pathway, and has an anti-apoptotic function in human glioblastoma-derived U373MG cells. Although ARF4 plays a role in cancer cells, the molecular mechanism underlying regulation of its expression and its exact functions in breast cancer are unknown. In this study, we investigated the regulatory mechanism of ARF4 expression and its involvement in breast cancer cell migration. Our results show that phorbol 12-myristate 13-acetate (PMA) treatment increases ARF4 expression at both the transcriptional and translational levels. We found that the novel transcription factor small leucine zipper protein (sLZIP) binds directly to the CRE motif of the -43 to -35 region in the ARF4 promoter and regulates PMA-induced ARF4 expression. We also found that PMA-stimulated ARF4 expression increases AP-1 promoter activity, leading to induction of breast cancer cell migration. These results indicate that sLZIP-regulated ARF4 expression in response to PMA is involved in breast cancer cell migration, and sLZIP and ARF4 are potential therapeutic target molecules for treating breast cancer invasion and metastasis.

[1]  Peter J Parker,et al.  PKC at a glance , 2004, Journal of Cell Science.

[2]  Y. Onodera,et al.  Requirement for Arf6 in breast cancer invasive activities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Moss,et al.  Structure and Function of ARF Proteins: Activators of Cholera Toxin and Critical Components of Intracellular Vesicular Transport Processes (*) , 1995, The Journal of Biological Chemistry.

[4]  Paul Melançon,et al.  ADP-ribosylation Factor 1 Controls the Activation of the Phosphatidylinositol 3-Kinase Pathway to Regulate Epidermal Growth Factor-dependent Growth and Migration of Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[5]  R. Lu,et al.  Luman/CREB3 Induces Transcription of the Endoplasmic Reticulum (ER) Stress Response Protein Herp through an ER Stress Response Element , 2006, Molecular and Cellular Biology.

[6]  J. Ko,et al.  A novel isoform of human LZIP negatively regulates the transactivation of the glucocorticoid receptor. , 2009, Molecular endocrinology.

[7]  Michael P Heldebrant,et al.  Phorbol 12-myristate 13-Acetate Inhibits Death Receptor-mediated Apoptosis in Jurkat Cells by Disrupting Recruitment of Fas-associated Polypeptide with Death Domain* , 2002, The Journal of Biological Chemistry.

[8]  D. Hirsch,et al.  Arf and its many interactors. , 2003, Current opinion in cell biology.

[9]  Woojin Jun,et al.  HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells , 2010, Cellular and Molecular Life Sciences.

[10]  G. Romero,et al.  ARF proteins mediate insulin-dependent activation of phospholipase D , 1997, Current Biology.

[11]  Crislyn D'Souza-Schorey,et al.  ARF proteins: roles in membrane traffic and beyond , 2006, Nature Reviews Molecular Cell Biology.

[12]  Hans van Dam,et al.  Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis , 2001, Oncogene.

[13]  P. Blumberg,et al.  Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. , 1988, Cancer research.

[14]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[15]  E. Wagner,et al.  AP-1 in mouse development and tumorigenesis , 2001, Oncogene.

[16]  H. Schwarz,et al.  Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion , 1992, Cell.

[17]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[18]  Jiing-Dwan Lee,et al.  ADP-ribosylation Factor 4 Small GTPase Mediates Epidermal Growth Factor Receptor-dependent Phospholipase D2 Activation* , 2003, The Journal of Biological Chemistry.

[19]  H. Schröder,et al.  ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2. , 2009, Cellular signalling.

[20]  Y Nishizuka,et al.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. , 1982, The Journal of biological chemistry.

[21]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[22]  G. Romero,et al.  ADP-ribosylation Factor Proteins Mediate Agonist-induced Activation of Phospholipase D* , 1998, The Journal of Biological Chemistry.

[23]  V. Misra,et al.  Luman, the Cellular Counterpart of Herpes Simplex Virus VP16, Is Processed by Regulated Intramembrane Proteolysis , 2002, Molecular and Cellular Biology.

[24]  Chang Woo Han,et al.  Identification of ADP-ribosylation factor 4 as a suppressor of N-(4-hydroxyphenyl)retinamide-induced cell death. , 2009, Cancer letters.

[25]  K. Leach,et al.  Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands. , 1984, Biochemical pharmacology.

[26]  A. Wilson,et al.  N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the host cell factor-1 binding motif. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Yusuf A. Hannun,et al.  Regulation of protein kinase C and role in cancer biology , 1994, Cancer and Metastasis Reviews.

[28]  X. Su,et al.  ADP-ribosylation factor 6 modulates adrenergic stimulated lipolysis in adipocytes. , 2010, American journal of physiology. Cell physiology.

[29]  J. Rothman,et al.  Mechanisms of intracellular protein transport , 1994, Nature.

[30]  M. Kazanietz,et al.  New insights into the regulation of protein kinase C and novel phorbol ester receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  Seng-Lai Tan,et al.  Emerging and diverse roles of protein kinase C in immune cell signalling. , 2003, The Biochemical journal.

[32]  V. Misra,et al.  Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor , 1997, Molecular and cellular biology.

[33]  J. Moss,et al.  Molecules in the ARF Orbit* , 1998, The Journal of Biological Chemistry.

[34]  S. Jaken.  Protein kinase C isozymes and substrates. , 1996, Current opinion in cell biology.

[35]  Hong-Hee Kim,et al.  Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1‐dependent chemokines , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.